MS Drugs Delay Conversion to Secondary Progressive Disease MS Drugs Delay Conversion to Secondary Progressive Disease

A new study suggests that secondary progressive MS is at least partially a consequence of early inflammation and that the risk for conversion from relapsing-remitting to the progressive form is modifiable with existing therapies.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news